Corrigendum to: "Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions" [J. Clin. Virol. 35 (2006) 270-277] (DOI:10.1016/j.jcv.2005.09.001);Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions

Journal of Clinical Virology

Volumn 35, Issue 3, 2006, Pages 270-277

  Monnier Benoit, S ^a   Dalstein, V ^a   Riethmuller, D ^b   Lalaoui, N ^a   Mougin, C ^a   Pretet J L ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Cervical intraepithelial neoplasia (CIN); HPV16 DNA load; Human papillomavirus (HPV); Quantitative real time PCR

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INCIDENCE; LONGITUDINAL STUDY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD;

EID: 31944446944     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.08.002     Document Type: Erratum

References (40)

1. J.P. Bory, J. Cucherousset, M. Lorenzato, R. Gabriel, C. Quéreux, and P. Birembaut Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women Int J Cancer 102 5 2002 519 525
2. F.X. Bosch, M.M. Manos, N. Muñoz, M. Sherman, A.M. Jansen, J. Peto International biological study on cervical cancer (IBSCC) Study Group Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J Natl Cancer Inst 87 11 1995 796 802
3. C. Clavel, J. Cucherousset, M. Lorenzato, S. Caudroy, J.M. Nou, and P. Nazeyrollas Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions Br J Cancer 90 9 2004 1803 1808
4. C.P. Crum, K.J. Beach, M.L. Hedley, L. Yuan, K.R. Lee, and T.C. Wright Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol J Infect Dis 189 8 2004 1348 1354
5. V. Dalstein, D. Riethmuller, J.L. Prétet, K. Le Bail Carval, J.L. Sautière, and J.P. Carbillet Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study Int J Cancer 106 3 2003 396 403
6. V. Dalstein, D. Riethmuller, J.L. Sautière, J.L. Prétet, B. Kantelip, and J.P. Schaal Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus Eur J Cancer 40 8 2004 1225 1232
7. M.H. Einstein, and R.D. Burk Persistent human papillomavirus infection: definitions and clinical implications Papillomavirus Rep 12 2001 119 123
8. Exbrayat C. Col de l'utérus. Evolution de l'incidence et de la mortalité par cancer en France de 1978 à 2000. In: Remontet L, Buemi A, Velten M, Jougla E, Estève J, editors. Paris: Actis; 2003. p. 107-12.
9. P.E. Gravitt, C. Peyton, C. Wheeler, R. Apple, R. Higuchi, and K.V. Shah Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays J Virol Methods 112 1-2 2003 23 33
10. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 7 1998 423 428
11. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, and P. Palan Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst 87 18 1995 1365 1371
12. R.A. Hubbard Human papillomavirus testing methods Arch Pathol Lab Med 127 8 2003 940 945
13. A.M. Josefsson, P.K. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, and P.K. Andersen Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study Lancet 355 9222 2000 2189 2193
14. R. Klaes, S.M. Woerner, R. Ridder, N. Wentzensen, M. Duerst, and A. Schneider Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes Cancer Res 59 24 1999 6132 6136
15. L.A. Koutsky, K.K. Holmes, C.W. Critchlow, C.E. Stevens, J. Paavonen, and A.M. Beckmann A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 18 1992 1272 1278
16. L. Lamarcq, J. Deeds, D. Ginzinger, J. Perry, S. Padmanabha, and K. Smith-McCune Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening J Mol Diagn 4 2 2002 97 102
17. I. Laurendeau, M. Bahuau, N. Vodovar, C. Larramendy, M. Olivi, and I. Bieche TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency Clin Chem 45 7 1999 982 986
18. K.W. Lo, S.W. Yeung, T.H. Cheung, N.S. Siu, T. Kahn, and Y.F. Wong Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: A study in Chinese population J Clin Virol 2005
19. A.T. Lorincz, and R.M. Richart Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs Arch Pathol Lab Med 127 8 2003 959 968
20. M. Moberg, I. Gustavsson, and U. Gyllensten Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer J Clin Microbiol 41 7 2003 3221 3228
21. M. Moberg, I. Gustavsson, and U. Gyllensten Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ Int J Cancer 112 5 2004 854 859
22. T. Molden, I. Kraus, F. Karlsen, H. Skomedal, J.F. Nygard, and B. Hagmar Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion Cancer Epidemiol Biomarkers Prev 14 2 2005 367 372
23. S. Nagao, M. Yoshinouchi, Y. Miyagi, A. Hongo, J. Kodama, and S. Itoh Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR J Clin Microbiol 40 3 2002 863 867
24. M.A. Nobbenhuis, C.J. Meijer, A.J. van den Brule, L. Rozendaal, F.J. Voorhorst, and E.K. Risse Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia Br J Cancer 84 6 2001 796 801
25. M.A. Nobbenhuis, J.M. Walboomers, T.J. Helmerhorst, L. Rozendaal, A.J. Remmink, and E.K. Risse Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study Lancet 354 9172 1999 20 25
26. P. Peitsaro, B. Johansson, and S. Syrjanen Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique J Clin Microbiol 40 3 2002 886 891
27. K.U. Petry, G. Bohmer, T. Iftner, P. Davies, O. Brummer, and H. Kuhnle Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia Am J Obstet Gynecol 186 1 2002 28 34
28. J-L. Prétet, V. Dalstein, S. Monnier-Benoit, S. Delpeut, and C. Mougin High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women J Clin Virol 31 2 2004 140 147
29. A.J. Remmink, J.M. Walboomers, T.J. Helmerhorst, F.J. Voorhorst, L. Rozendaal, and E.K. Risse The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months Int J Cancer 61 3 1995 306 311
30. N.F. Schlecht, S. Kulaga, J. Robitaille, S. Ferreira, M. Santos, and R.A. Miyamura Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 24 2001 3106 3114
31. N.F. Schlecht, A. Trevisan, E. Duarte-Franco, T.E. Rohan, A. Ferenczy, and L.L. Villa Viral load as a predictor of the risk of cervical intraepithelial neoplasia Int J Cancer 103 4 2003 519 524
32. P.J. Snijders, A.J. van den Brule, and C.J. Meijer The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity J Pathol 201 1 2003 1 6
33. D. Solomon, M. Schiffman, and R. Tarone Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial J Natl Cancer Inst 93 4 2001 293 299
34. D.C. Swan, R.A. Tucker, G. Tortolero-Luna, M.F. Mitchell, L. Wideroff, and E.R. Unger Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type J Clin Microbiol 37 4 1999 1030 1034
35. C.L. Trimble, S. Piantadosi, P. Gravitt, B. Ronnett, E. Pizer, and A. Elko Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype Clin Cancer Res 11 13 2005 4717 4723
36. M. van Duin, P.J. Snijders, H.F. Schrijnemakers, F.J. Voorhorst, L. Rozendaal, and M.A. Nobbenhuis Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance Int J Cancer 98 4 2002 590 595
37. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1 1999 12 19
38. S.J. Weissenborn, A.M. Funke, M. Hellmich, P. Mallmann, P.G. Fuchs, and H.J. Pfister Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated J Clin Microbiol 41 6 2003 2763 2767
39. N. Ylitalo, P. Sorensen, A.M. Josefsson, P.K. Magnusson, P.K. Andersen, and J. Ponten Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study Lancet 355 9222 2000 2194 2198
40. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 5 2002 342 350